LiverRight and Aegle Medical Solutions, LLC have announced a strategic partnership aimed at expanding access to non-invasive liver assessment, specialist interpretation, diagnosis, and ongoing liver care for patients throughout the United States. The collaboration combines Aegle Medical's advanced liver assessment technology with LiverRight's national virtual liver clinic, creating a more connected pathway from liver disease identification to longitudinal management.
The partnership addresses a critical gap in liver care: a significant number of adults in the United States live with undiagnosed liver disease. By integrating Aegle Medical's technology solutions and support services with LiverRight's specialist network, the two organizations aim to help physicians and healthcare organizations establish or expand comprehensive liver disease programs without building every component internally. Aegle Medical provides advanced liver assessment technology, including the Mindray Hepatus-Series Transient Elastography Diagnostic Ultrasound Systems, along with implementation, clinical training, and ongoing customer support. LiverRight offers same-day interpretation services for liver elastography studies and same-week virtual access to its hepatology clinicians through its Liververse™ referral system, which coordinates bloodwork, patient-reported outcomes, imaging, diagnosis, and longitudinal disease management.
For patients, the combined model is designed to bring advanced liver assessment closer to the communities where they already receive care, while improving access to liver specialists. The goal is to create a more efficient pathway from identifying at-risk patients to non-invasive assessment, specialist review, diagnosis, and appropriate ongoing care. This is particularly important for communities where access to hepatology specialists may be limited.
Brandon Tudor, CEO of LiverRight, stated that Aegle Medical Solutions is helping hospital systems and independent practices nationwide address the significant number of adults living with undiagnosed liver disease. By working together, the partnership helps practices bring advanced liver assessment into the outpatient setting, provide timely specialist interpretation, and move patients into the appropriate diagnostic and care workflow with greater efficiency.
Michael McTighe, President & CEO of Aegle Medical Solutions, noted that the strategic partnership represents an important step forward in expanding access to liver disease detection and care within the communities they serve. He emphasized that by connecting Aegle Medical's capabilities with LiverRight's nationwide virtual liver-care network and same-day interpretation services, customers receive more than technology—they gain a more complete pathway from assessment to diagnosis and ongoing patient management. McTighe added that this model can be particularly valuable for communities with limited access to hepatology specialists, aiming to identify liver disease earlier, improve access to specialist expertise, and create a better experience for patients and clinicians.
Central to the partnership is the Mindray Hepatus platform, which represents a next generation in non-invasive liver assessment. It introduces Visualized Transient Elastography (ViTE), a breakthrough that integrates real-time B-mode ultrasound visualization directly into the elastography examination. Unlike conventional transient elastography platforms that rely primarily on measurement data without real-time anatomical visualization, ViTE enables operators to see liver anatomy, identify the optimal measurement location, and visually guide each acquisition while obtaining quantitative liver stiffness and attenuation measurements. This evolution combines the efficiency of transient elastography with the clinical confidence of real-time ultrasound visualization in a single examination.
The Hepatus platform is designed to streamline examinations with a more efficient, b-mode image-guided workflow, providing liver stiffness measurement for fibrosis assessment and Liver UltraSound Attenuation for quantitative assessment of hepatic steatosis. The Hepatus 6 further expands the platform by combining these capabilities with diagnostic ultrasound imaging, allowing clinicians to utilize the system for abdominal imaging, Doppler, spleen stiffness assessment, and intestinal ultrasound, depending on configuration. This creates a versatile platform capable of supporting a broader range of hepatology and gastroenterology applications.
LiverRight has its own hepatologists and hepatology advanced practice providers licensed across all 50 U.S. states. Its clinicians support adult patients with liver conditions including MASLD/MASH, alcohol-associated liver disease, hepatitis B and C, primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis, and liver cancer diagnosis. The Aegle Medical–LiverRight strategic relationship gives health systems, GI and hepatology practices, and independent providers a scalable approach to expanding liver services by combining access to advanced non-invasive liver assessment technology, implementation and clinical support, timely specialist interpretation, and a pathway to continued liver care—all under the provider's brand.
